Pirfenidone Tablet, Coated
Product Images NDC 76282-716

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 76282-716). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pirfenidone Figure1)

This is a table that compares the absolute change in %FVC (Forced Vital Capacity) from baseline to week 52 between two groups of patients: those who received Pifenidone and those who received a placebo. The percentage of patients who experienced worsening or improvement of %FVC are shown as well. No further information beyond what is presented in the table is available.*

FDA Label Image

Figure 2 (Pirfenidone Figure2)

The text is providing data on the mean change in Forced Vital Capacity (FVC) in milliliters after a particular period of time for two groups- one group receiving Piferidone (n=278) and the other group receiving Placebo (n=277). However, the details and context of the study are not available.*

FDA Label Image

Figure 3 (Pirfenidone Figure3)

The text describes the percentage of patients alive and the comparison between Pirferidone and Placebo medication. However, it's difficult to provide a conclusive description based on the given text, due to the lack of clarity in sentences as they appear to be broken apart.*

FDA Label Image

801 mg (Pirfenidone Pdp 1)

FDA Label Image

801 mg (Pirfenidone Pdp 2)

This is a description of a medication that is a film-coated tablet containing 801mg of pirfenidone. The usual dosage should be checked from the package insert for full prescribing information. The tablet should be stored at 25°C (77°F) but can be stored in excursions permitted to 15° to 30°C (59° to 86°F). It is manufactured for Exelan Pharmaceuticals, Inc. and manufactured by ScieGen Pharmaceuticals, Inc. The medication is Rx only and comes in a bottle with 270 tablets.*

FDA Label Image

267 mg (Pirfenidone Pdp 5)

This is a description of Pirfenidone Tablets, a prescription medication containing 267mg of pirfenidone per film-coated tablet. The storage temperature range is between 15° to 30°C, with the ideal temperature at 25°C. It is important to keep the medication out of reach of children. The drug is manufactured by ScieGen Pharmaceuticals and distributed by Exelan Pharmaceuticals. However, the last line appears to be non-English characters and thus the description is incomplete.*

FDA Label Image

267 mg (Pirfenidone Pdp 6)

This is the description of Pirfenidone tablets which come in a film-coated form containing 267 mg of the medicine. The recommended dosage should be seen from the package insert. It should be stored between 15°C to 30°C (59°F to 86°F), and one should keep it away from children. Exelan Pharmaceuticals, Inc. has manufactured it and is distributed by ScieGen Pharmaceuticals, Inc. This medicine is only available with a prescription.*

FDA Label Image

Pirfenidone (Pirfenidone Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.